SCHEMBL25824027

SCHEMBL25824027

CC(=O)C1CCc2cc(O)ccc2O1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.55
ESR2 Q92731 4/20 0.55
CYP4F2 P78329 1/20 0.47
CYP4A11 Q02928 1/20 0.47
NFKB1 P19838 2/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
MAPK1 P28482 2/20 0.40
HSD17B10 Q99714 2/20 0.40
AKR1C3 P42330 1/20 0.40
TSHR P16473 1/20 0.40
LMNA P02545 2/20 0.39
CYP3A4 P08684 2/20 0.39
MEN1 O00255 1/20 0.39
ALOX15 P16050 1/20 0.39
BRCA1 P38398 1/20 0.39
RECQL P46063 1/20 0.39
KMT2A Q03164 1/20 0.39
AKR1B10 O60218 1/20 0.39
SHBG P04278 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5839879 0.86 ESR1 (0.56) ESR1ESR2CYP4F2CYP4A11NFKB1
SCHEMBL7290410 0.86 ESR1 (0.56) ESR1ESR2CYP4F2CYP4A11NFKB1
SCHEMBL4193774 0.86 ESR1 (0.56) ESR1ESR2CYP4F2CYP4A11NFKB1
SCHEMBL17324786 0.84 POLB (0.49) ESR1ESR2NFKB1NFKB2RELA
SCHEMBL29052788 0.84 CYP4F2 (0.53) ESR1ESR2CYP4F2CYP4A11NFKB1
SCHEMBL22424771 0.84 ESR1 (0.51) ESR1ESR2CYP4F2CYP4A11NFKB1
SCHEMBL20876956 0.83 CYP4F2 (0.46) ESR1ESR2CYP4F2CYP4A11NFKB1
SCHEMBL13766519 0.83 MLNR (0.49) CYP4F2CYP4A11NFKB1NFKB2RELA
SCHEMBL3909221 0.83 MLNR (0.49) CYP4F2CYP4A11NFKB1NFKB2RELA
SCHEMBL13766518 0.83 MLNR (0.49) CYP4F2CYP4A11NFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3606522-B1 NOVEL TREATMENT OF MITOCHONDRIAL DISEASES KHONDRION IP B V (NL) 2023-07-12 EP disclosed